The near death — and last-minute reprieve — of a trial for an HIV vaccine [NPR] ↳

A pan-African HIV vaccine trial originally set to begin with substantial U.S. funding was thrown into jeopardy last year when foreign aid was abruptly cut. According to NPR, even amid those setbacks and a reduced scope, the downsized trial has now started enrolling participants, offering cautious hope that advancing vaccine research.